Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 1726 AL 1740

Unlocking the therapeutic potential of natural stilbene: Exploring pterostilbene as a powerful ally against aging and cognitive decline

Dutta BJ, Rakshe PS, Maurya N, Chib S, Singh S.

Ageing Res Rev. 2023 Dec;92:102125. doi: 10.1016/j.arr.2023.102125. Epub 2023 Nov 17.

Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden

Lyon M, Fullerton JL, Kennedy S, Work LM.

Pharmacol Ther. 2024 Jan;253:108575. doi: 10.1016/j.pharmthera.2023.108575. Epub 2023 Dec 3.

Transcranial direct current stimulation of the right temporoparietal junction facilitates hippocampal spatial learning in Alzheimer's disease and mild cognitive impairment

Philippen S, Hanert A, Schönfeld R, Granert O, Yilmaz R, Jensen-Kondering U, Splittgerber M, Moliadze V, Siniatchkin M, Berg D, Bartsch T.

Clin Neurophysiol. 2024 Jan;157:48-60. doi: 10.1016/j.clinph.2023.11.003. Epub 2023 Nov 15.

NeuroEPO plus (NeuralCIM(®)) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial

Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators.

Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w.

Deep Brain Stimulation as an Emerging Therapy for Cognitive Decline in Alzheimer Disease: Systematic Review of Evidence and Current Targets

Picton B, Wong J, Lopez AM, Solomon SS, Andalib S, Brown NJ, Dutta RR, Paff MR, Hsu FP, Oh MY.

World Neurosurg. 2024 Apr;184:253-266.e2. doi: 10.1016/j.wneu.2023.12.083. Epub 2023 Dec 21.

Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhai Z, Kong F, Zhu Z, Dai J, Cai J, Xie D, Shen Y, Xu Y, Sun T.

Am J Geriatr Psychiatry. 2024 May;32(5):555-583. doi: 10.1016/j.jagp.2023.11.011. Epub 2023 Dec 7.

The Role of TNF-α in Alzheimer's Disease: A Narrative Review

Plantone D, Pardini M, Righi D, Manco C, Colombo BM, De Stefano N.

Cells. 2023 Dec 26;13(1):54. doi: 10.3390/cells13010054.

Chitosan hydrogel nanoparticle enhance therapeutic effect of bovine umbilical mesenchymal stem cell conditioned medium on canine cognitive dysfunction or canine Alzheimer's like mediated by inhibition of neuronal apoptotic

Wihadmadyatami H, Zulfikar MA, Herawati H, Pratama DAOA, Saragih GR, Kustiati U, Handayani AN.

Open Vet J. 2023 Dec;13(12):1504-1516. doi: 10.5455/OVJ.2023.v13.i12.1. Epub 2023 Dec 31.

Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets

Vakili O, Asili P, Babaei Z, Mirahmad M, Keshavarzmotamed A, Asemi Z, Mafi A.

CNS Neurol Disord Drug Targets. 2023;22(9):1335-1354. doi: 10.2174/1871527321666220829164211.

Clinical Biomarkers and Novel Drug Targets to Cut Gordian Knots of Alzheimer's Disease

Shah AJ, Mohi-Ud-Din R, Sabreen S, Wani TU, Jan R, Javed MN, Mir PA, Mir RH, Masoodi MH.

Curr Mol Pharmacol. 2023;16(3):254-279. doi: 10.2174/1874467215666220903095837.

CSF biomarker concordance with amyloid PET in Phase 3 studies of aducanumab

Nisenbaum L, Martone R, Chen T, Rajagovindan R, Dent G, Beaver J, Rubel C, Racine A, He P, Harrison K, Dean R, Vandijck M, Haeberlein SB.

Alzheimers Dement. 2023 Aug;19(8):3379-3388. doi: 10.1002/alz.12919. Epub 2023 Feb 16.

Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: Convergence or divergence? Lessons from Alzheimer's disease and synucleinopathies

Sensi SL, Russo M, Tiraboschi P.

Handb Clin Neurol. 2023;192:187-218. doi: 10.1016/B978-0-323-85538-9.00015-8.

Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications

Gonzalez-Ortiz F, Kac PR, Brum WS, Zetterberg H, Blennow K, Karikari TK.

Mol Neurodegener. 2023 Mar 16;18(1):18. doi: 10.1186/s13024-023-00605-8.

Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease

Xu Y, Jiang H, Zhu B, Cao M, Feng T, Sun Z, Du G, Zhao Z.

CNS Neurosci Ther. 2023 Aug;29(8):2060-2073. doi: 10.1111/cns.14238. Epub 2023 May 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias